These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17038144)

  • 1. Spatial distribution of repolarization and depolarization abnormalities evaluated by body surface potential mapping in patients with Brugada syndrome.
    Yokokawa M; Takaki H; Noda T; Satomi K; Suyama K; Kurita T; Kamakura S; Shimizu W
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1112-21. PubMed ID: 17038144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
    Nagase S; Kusano KF; Morita H; Nishii N; Banba K; Watanabe A; Hiramatsu S; Nakamura K; Sakuragi S; Ohe T
    J Am Coll Cardiol; 2008 Mar; 51(12):1154-61. PubMed ID: 18355652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome.
    Chinushi M; Komura S; Izumi D; Furushima H; Tanabe Y; Washizuka T; Aizawa Y
    Pacing Clin Electrophysiol; 2007 May; 30(5):662-71. PubMed ID: 17461877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between depolarization abnormality and repolarization abnormality in patients with Brugada syndrome: using body surface signal-averaged electrocardiography and body surface maps.
    Hisamatsu K; Kusano KF; Morita H; Takenaka S; Nagase S; Nakamura K; Emori T; Matsubara H; Mikouchi H; Nishizaki Y; Ohe T
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):870-6. PubMed ID: 15333077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in brugada syndrome a study of electrocardiograms, vectorcardiograms, and body surface potential maps during ajmaline provocation.
    Postema PG; van Dessel PF; Kors JA; Linnenbank AC; van Herpen G; Ritsema van Eck HJ; van Geloven N; de Bakker JM; Wilde AA; Tan HL
    J Am Coll Cardiol; 2010 Feb; 55(8):789-97. PubMed ID: 20170818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in body surface potential distributions induced by isoproterenol and Na channel blockers in patients with the Brugada syndrome.
    Izumida N; Asano Y; Doi S; Wakimoto H; Fukamizu S; Kimura T; Ueyama T; Sakurada H; Kawano S; Sawanobori T; Hiraoka M
    Int J Cardiol; 2004 Jun; 95(2-3):261-8. PubMed ID: 15193830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome.
    Sarkozy A; Chierchia GB; Paparella G; Boussy T; De Asmundis C; Roos M; Henkens S; Kaufman L; Buyl R; Brugada R; Brugada J; Brugada P
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):154-61. PubMed ID: 19808460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repolarization heterogeneity in the right ventricular outflow tract: correlation with ventricular arrhythmias in Brugada patients and in an in vitro canine Brugada model.
    Morita H; Zipes DP; Fukushima-Kusano K; Nagase S; Nakamura K; Morita ST; Ohe T; Wu J
    Heart Rhythm; 2008 May; 5(5):725-33. PubMed ID: 18452878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does early repolarization in the athlete have analogies with the Brugada syndrome?
    Bianco M; Bria S; Gianfelici A; Sanna N; Palmieri V; Zeppilli P
    Eur Heart J; 2001 Mar; 22(6):504-10. PubMed ID: 11237546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conduction delay in right ventricle as a marker for identifying high-risk patients with Brugada syndrome.
    Doi A; Takagi M; Maeda K; Tatsumi H; Shimeno K; Yoshiyama M
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):688-96. PubMed ID: 20050961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study.
    Aiba T; Shimizu W; Hidaka I; Uemura K; Noda T; Zheng C; Kamiya A; Inagaki M; Sugimachi M; Sunagawa K
    J Am Coll Cardiol; 2006 May; 47(10):2074-85. PubMed ID: 16697328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilsicainide-induced ST segment elevation and ST segment depression in two patients with variant forms of Brugada-type electrocardiographic abnormalities.
    Chinushi M; Tagawa M; Izumi D; Furushima H; Aizawa Y
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):811-5. PubMed ID: 19545347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular repolarization restitution properties in patients exhibiting type 1 Brugada electrocardiogram with and without inducible ventricular fibrillation.
    Hayashi M; Takatsuki S; Maison-Blanche P; Messali A; Haggui A; Milliez P; Leenhardt A; Extramiana F
    J Am Coll Cardiol; 2008 Mar; 51(12):1162-8. PubMed ID: 18355653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.
    Shimizu W; Antzelevitch C; Suyama K; Kurita T; Taguchi A; Aihara N; Takaki H; Sunagawa K; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1320-9. PubMed ID: 11196553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST-Segment Elevation and Fractionated Electrograms in Brugada Syndrome Patients Arise From the Same Structurally Abnormal Subepicardial RVOT Area but Have a Different Mechanism.
    Ten Sande JN; Coronel R; Conrath CE; Driessen AH; de Groot JR; Tan HL; Nademanee K; Wilde AA; de Bakker JM; van Dessel PF
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1382-92. PubMed ID: 26480928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between dominant prolongation of the filtered QRS duration in the right precordial leads and clinical characteristics in Brugada syndrome.
    Furushima H; Chinushi M; Hirono T; Sugiura H; Watanabe H; Komura S; Washizuka T; Aizawa Y
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1311-7. PubMed ID: 16403063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome.
    Morita H; Kusano KF; Miura D; Nagase S; Nakamura K; Morita ST; Ohe T; Zipes DP; Wu J
    Circulation; 2008 Oct; 118(17):1697-704. PubMed ID: 18838563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetocardiography study on ventricular depolarization-current pattern in patients with brugada syndrome and complete right-bundle branch blocks.
    Kandori A; Miyashita T; Ogata K; Shimizu W; Yokokawa M; Kamakura S; Miyatake K; Tsukada K; Yamada S; Watanabe S; Yamaguchi I
    Pacing Clin Electrophysiol; 2006 Dec; 29(12):1359-67. PubMed ID: 17201843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of conduction delay in the right ventricular outflow tract between Brugada syndrome and right ventricular cardiomyopathy: investigation of signal average ECG in the precordial leads.
    Furushima H; Chinushi M; Okamura K; Iijima K; Komura S; Tanabe Y; Okada S; Izumi D; Aizawa Y
    Europace; 2007 Oct; 9(10):951-6. PubMed ID: 17636305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms.
    Shimizu W; Matsuo K; Takagi M; Tanabe Y; Aiba T; Taguchi A; Suyama K; Kurita T; Aihara N; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Apr; 11(4):396-404. PubMed ID: 10809492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.